JHVEPhoto/iStock Editorial via Getty Images Amgen ( NASDAQ: AMGN ) is scheduled to announce Q3 earnings results on Wednesday, October 30th, after market close. Investors and analysts will be looking for updates on the mid-stage trial of Amgen’s ( AMGN ) lead weight loss candidate, MariTide, although BMO Capital Markets’ Evan David.
Back to Health Page
